Key takeaways
- • Severity: Major — avoid or close monitoring.
- • Wegovy (weight management (FDA-approved obesity)) and Glipizide (Glucotrol) (Sulfonylurea (diabetes)).
- • Clinical management: Sulfonylurea is commonly reduced or discontinued when semaglutide is initiated. Prescriber decides whether to taper or stop.
- • Monitoring: Increased glucose monitoring during semaglutide initiation and escalation; A1c per usual.
Mechanism
Sulfonylureas stimulate insulin secretion regardless of glucose level, so combining with semaglutide produces additive hypoglycemia risk. Unlike GLP-1 monotherapy, which carries low intrinsic hypoglycemia risk, the combination can cause clinically significant lows.
Clinical management
Sulfonylurea is commonly reduced or discontinued when semaglutide is initiated. Prescriber decides whether to taper or stop.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Wegovy or Glipizide (Glucotrol).
Monitoring
Increased glucose monitoring during semaglutide initiation and escalation; A1c per usual.
When to call your doctor
- hypoglycemia symptoms (sweating, tremor, confusion)
- loss of consciousness
- frequent low readings
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Ozempic and Wegovy USPI Warnings and Precautions discuss hypoglycemia risk with insulin secretagogues.
Editorial confidence: 10/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Glipizide (Glucotrol) with Wegovy?
High clinical risk — discuss with your prescriber before combining. Sulfonylurea is commonly reduced or discontinued when semaglutide is initiated. Prescriber decides whether to taper or stop. Always confirm the specific plan with your prescriber — this page summarizes general pharmacology, not personal medical advice.
What's the mechanism of any Wegovy + Glipizide (Glucotrol) interaction?
Sulfonylureas stimulate insulin secretion regardless of glucose level, so combining with semaglutide produces additive hypoglycemia risk. Unlike GLP-1 monotherapy, which carries low intrinsic hypoglycemia risk, the combination can cause clinically significant lows.
What should I monitor when on Wegovy + Glipizide (Glucotrol)?
Increased glucose monitoring during semaglutide initiation and escalation; A1c per usual.
When should I call my doctor?
Contact your prescriber if you notice any of: hypoglycemia symptoms (sweating, tremor, confusion); loss of consciousness; frequent low readings.
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.